CTOs on the Move

Axonics Modulation Technologies

www.axonics.com

 
Axonics Modulation Technologies, Inc is a privately-held medical device company developing an innovative neuromodulation platform based on a miniaturized rechargeable fully-implantable IPG licensed from the Alfred Mann Foundation. The Axonics Sacral Neuromodulation System is designed to improve the experience of both clinicians and patients suffering from Urinary and Fecal dysfunction.
  • Number of Employees: 100-250
  • Annual Revenue: $0-1 Million
  • www.axonics.com
  • 7575 Irvine Center Drive Suite 200
    Irvine, CA USA 92618
  • Phone: 949.396.6322

Executives

Name Title Contact Details

Funding

Axonics Modulation Technologies raised $38.5M on 12/22/2015
Axonics Modulation Technologies raised $14.5M on 05/02/2017
Axonics Modulation Technologies raised $20.5M on 07/06/2017
Axonics Modulation Technologies raised $20M on 04/03/2018
Axonics Modulation Technologies raised $110M on 11/22/2019
Axonics Modulation Technologies raised $17M on 12/13/2019
Axonics Modulation Technologies raised $201.3M on 05/14/2021

Similar Companies

Walters Healthcare Resources

Walters Healthcare Resources is a Palmer, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Viaflo

Viaflo is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Clarify Health

At Clarify, we are improving the lives of patients and those who care for them by building the brains of the digital healthcare system of the future. We partner with forward-looking providers and payers to optimize episode workflows, improve patient experience, increase volume, and maximize bonuses. We deliver innovative digital and analytics solutions that enable patients to obtain, and our customers to deliver, more satisfying, better outcome, higher value healthcare.

Pentax Medical

PENTAX Medical is a division of Hoya Group. Its mission is to improve the standard of patient care and quality of healthcare delivery by providing the best endoscopic products and services with a focus on QUALITY, CLINICALLY RELEVANT INNOVATION, and SIMPLICITY.   Through leading-edge R&D and manufacturing, PENTAX Medical provides endoscopic imaging devices and solutions to the global medical community. Headquartered in Japan, PENTAX Medical has a worldwide focus and presence with R&D, regional sales, service, and in-country facilities around the globe.   PENTAX Medical employees represent the diverse countries where we do business, allowing us to provide innovative solutions tailored to meet local needs.

Endologix

Endologix, Inc. develops and manufactures minimally invasive treatments for aortic disorders. The Company`s focus is endovascular stent grafts for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. The overall patient mortality rate for ruptured AAA is approximately 75%, making it a leading cause of death in the U.S. Approximately 1.7 million Americans have AAA, and the incidence of the condition increases with age. Endologix is currently marketing the AFX® Endovascular AAA System is available in the U.S., Europe, Latin America and other regions. The Nellix® EndoVascular Aneurysm Sealing System, a novel aneurysm sealing system, is approved for sale in Europe and other markets and for investigational use in the U.S. The Powerlink with IntuiTrak® Delivery System is available in Japan. These technologies are minimally invasive, allowing for greater patient comfort and quicker recovery compared to invasive surgical alternatives. Endologix products are protected by at least 52 U.S. patents with at least 956 allowed claims. Endologix is a publicly-held company trading on NASDAQ: ELGX. The Company`s corporate office is located in Irvine, California.